NKF Spring Clinical Meetings 2020
Patients with end-stage renal disease (ESRD) due to symptomatic autosomal dominant polycystic kidney disease (ADPKD) may ...
Guidelines from Kidney Disease Improving Global Outcomes recommend that all patients with end-stage renal disease (ESRD) ...
Optiflux® dialyzers, single-use, high-flux dialyzers, are available in four sizes: F160 NR (1.5 m2), F180NR (1.7 m2), ...
More than one-third of patients diagnosed with end-stage renal disease (ESRD) were not receiving care from a ...
Due to high medication burden and the presence of multiple comorbidities, patients with chronic kidney disease (CKD) are ...
Results of the DIALIZE trial (NCT03303521) demonstrated that sodium zirconium cyclosilicate (SZC) reduced predialysis ...
Amy Larkin, PharmD, CHCP, and Kelly Hanley, DO, of Medscape Education, New York, New York, reported results of a study ...
It is difficult for patients to manage hyperkalemia with a strict diet. Amy Larkin, PharmD, CHCP, and Donald Blatherwick ...
Worldwide, the leading cause of chronic kidney disease is diabetes mellitus. According to data from the National Health ...
According to Amy Larkin, PharmD, CHCP, and colleague as the treatment of anemia in patients with chronic kidney disease ...
In phase 3 studies examining the efficacy of roxadustat for the treatment of anemia in patients with chronic kidney ...
In patients on hemodialysis using arteriovenous (AV) access on the ipsilateral side, hand ischemia is recognized as ...
Managing patients with hyperkalemia while improving patient outcomes requires clinicians to implement evolving standards ...
Hyperkalemia, a common complication in patients with chronic kidney disease (CKD), may be exacerbated by pharmacologic ...
Among patients receiving hemodialysis, blood pressure control presents challenges requiring multiple medications and ...
Surgical patients frequently experience acute kidney injury (AKI). AKI is associated with adverse effects on both ...
In patients with chronic kidney disease (CKD), complications associated with aging occur at younger ages compared with ...
The Cure Glomerulopathy Network (CureGN) is a multi-center, prospective, observational study of patients with primary ...
In patients with resistant hypertension, use of spironolactone reduces blood pressure. However, in patients with chronic ...
Patients with both end-stage heart failure and severely impaired kidney function are candidates for simultaneous ...
Worldwide, the leading cause of chronic kidney disease (CKD) is diabetes mellitus. According to data from the National ...
Physical exercise can improve symptoms, function, and mental health. However, many patients with renal disease do not ...
Rahul Dhawan, MD, and colleagues at Optum®, part of United Healthcare, Eden Prairie, Minnesota, conducted a study to ...
Jill Meyer, MD, of the California Institute of Renal Research, Chula Vista, California, presented results of a ...
Patients requiring red blood cell transfusions may experience reactions leading to allo-sensitization, or rarely ...
Management of anemia in patients receiving peritoneal dialysis carries more challenges compared with anemia management ...
Researchers at Medscape Education (New York, New York), conduced an analysis to determine whether clinical knowledge, ...
Patients with chronic kidney disease commonly develop metabolic acidosis and are at increased risk for complications ...
In patients with autosomal dominant polycystic kidney disease (ADPKD), the progressive nature of declining kidney ...
Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited kidney disease, accounts for 10% of ...
DM199, a recombinant form of endogenous human tissue kallikrein protein (KLK1), restores KLK1 levels and enables ...
There are few scientific-based data comparing clinical outcomes of erythropoiesis-stimulating agents (ESAs) in patients ...
Anemia is a common comorbidity in patients with chronic kidney disease (CKD); however, there are few data available on ...
Patients with chronic kidney disease (CKD) may experience both hyperkalemia and metabolic acidosis. Erin Cook, MD, and ...
In the United States, approximately 15% of adults have chronic kidney disease (CKD); of patients with non-dialysis ...
Studies have established metabolic acidosis as a risk factor for progression of chronic kidney disease (CKD). There are ...
Patients with metabolic acidosis face a wide range of adverse outcomes. The association between metabolic acidosis and ...
Advertisement
Advertisement
